FAQ/Help |
Calendar |
Search |
Today's Posts |
07-07-2020, 10:13 AM | #1 | |||
|
||||
Senior Member
|
People with MS are advised not to interrupt their immunomodulating drug treatments on account of the COVID-19 pandemic--according to Dr. Robert Fox, one of the leading authorities on MS, who is affiliated with the Cleveland Clinic Neurological Institute and the Mellen Center for MS:
COVID-19: Preventive Measures in Multiple Sclerosis Patients and Others on Immuno-Modulators
__________________
Repeal the law of gravity! MS diagnosed 1980. Type 2 diabetes, osteoarthritis, osteopenia. Avonex 2002-2005. Copaxone 6/4/07-5/15/10. Currently: Glatopa (generic Copaxone), 40mg 3 times/week, 12/16/20 - 3/16/24 |
|||
Reply With Quote |
|
|
Similar Threads | ||||
Thread | Forum | |||